People: UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

3,360JPY
22 Sep 2014
Price Change (% chg)

¥-45 (-1.32%)
Prev Close
¥3,405
Open
¥3,380
Day's High
¥3,400
Day's Low
¥3,350
Volume
64,000
Avg. Vol
138,583
52-wk High
¥4,345
52-wk Low
¥2,020

Search Stocks

Summary

Name Age Since Current Position

Masahiro Michishita

52 2013 Chairman of the Board, President, Representative Director

Hiroyuki Hashimoto

44 2012 Director of Finance, Director

Tatsuyoshi Hirano

54 2013 President of Subsidiary, Director

Fumihisa Nakata

45 2011 Director of Clinical Development, Director

Tadashi Nakamura

47 2011 Director

Tsutomu Narikiyo

2012 Independent Director

Biographies

Name Description

Masahiro Michishita

Mr. Masahiro Michishita has been serving as Chairman of the Board, President and Representative Director in UMN Pharma Inc. since March 28, 2013. He is also serving as Director in another Japan-based company. He is also a guest professor of Akita University, Japan. He used to work for JAFCO Co., Ltd., Pacific Rim Ventures, Co., Ltd. P&G Far East, Inc., the Boston Consulting Group and Eisai Co., Ltd. He received his Doctorate of Medicine from Kanazawa University and his Ph.D. degree in Medical Sciences from Kyoto University.

Hiroyuki Hashimoto

Mr. Hiroyuki Hashimoto has been serving as Director of Finance and Director in UMN Pharma Inc. since March 2012. He is also serving as Director in a subsidiary. He joined the Company and previously served as Manager of Business Planning Unit in the Company. He used to work for other three companies.

Tatsuyoshi Hirano

Mr. Tatsuyoshi Hirano has been serving as Director of UMN Pharma Inc., as well as President and Representative Director of a subsidiary, UNIGEN Inc., since March 28, 2013. Prior to that, he served as President and Representative Director of the Company, as well as Director of UNIGEN Inc. He joined the Company in January 2009 and served as Director of Finance. He used to work for other Japan-based companies, including Shin-Etsu Chemical Co., Ltd. He received his Bachelor's degree in Social Sciences from Hitotsubashi University in 1984 and his Master's degree in Economics from Johns Hopkins University.

Fumihisa Nakata

Mr. Fumihisa Nakata has been serving as Director of Clinical Development and Director in UMN Pharma Inc. since August 2011. He joined the Company in March 2010 and previously served as Director of Pharmaceutical Affairs in the Company. He used to work for other two Japan-based companies.

Tadashi Nakamura

Mr. Tadashi Nakamura has been serving as Director in UMN Pharma Inc. since September 2011. He is also serving as Director in a subsidiary. He joined the Company in September 2006. His previous titles include Director of Manufacturing Development and Director of Production Development in the Company. He used to work for other companies.

Tsutomu Narikiyo

Mr. Tsutomu Narikiyo has been serving as Independent Director in UMN Pharma Inc. since March 2012. He is also serving as Director in a subsidiary, as well as Director of in charge of Bioproject Group in New Business Promotion Unit in IHI Corporation.

Basic Compensation

Search Stocks